Connect Biopharma Holdings Limited stock is down -31.03% since 30 days ago. The next earnings date is Apr 9, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 November’s closed higher than October.
Connect Biopharma Holdings Limited focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes. The company was founded in 2012 and is headquartered in Taicang, China.